From clinical trials to clinical practice: predictors of response to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy.
Tumori 0 97 (2): 160-5.
Mazzoni Francesca, Rotella Virginia, Pratesi Nicola, Boni Luca, Simi Lisa, Orlando Claudio, Comin Camilla Eva, Maddau Cristina, Di Costanzo Frances
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 20, 2019
- Content source: